Invasive infection with Saccharomyces cerevisiae: report of three cases and review.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Reviews of Infectious Diseases

• Publication date

  1990-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/CLINIDS/12.3.406PMID 2193348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Emerging Role of Fusarium Infections in Patients with Cancer

  1988cited by this paper
• Saccharomyces cerevisiae fungemia: case report and review of the literature.

  1987influential reference
• Saccharomyces cerevisiae infections in man.

  1984influential reference
• Dissemination of yeasts after gastrointestinal inoculation in antibiotic-treated mice.

  1983cited by this paper
• Postoperative peritonitis caused by Saccharomyces cerevisiae.

  1982cited by this paper
• Postoperative Peritonitis Due to Saccharomyces Cerivisiae—Treated with Ketoconazole

  1982cited by this paper
• The prevalence of yeasts in clinical specimens from cancer patients.

  1980cited by this paper
• Saccharomyces cerevisiae septicemia.

  1980influential reference
• Evaluation of industrial yeasts for pathogenicity.

  1979cited by this paper
• Evaluation of the modified API 20C system for identification of clinically important yeasts

  1979cited by this paper
• Fever of unknown origin secondary to brewer's yeast ingestion.

  1976cited by this paper
• FUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE

  1975influential reference
• Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts.

  1975influential reference
• Saccharomyces fungemia.

  1970cited by this paper
• Fungaemia and funguria after oral administration of Candida albicans.

  1969cited by this paper
• Translocation of microorganisms across the intestinal wall of the rat: effect of microbial size and concentration.

  1966cited by this paper
• Saccharomyces carlsbergensis, possibly a pathogen.

  1958cited by this paper
• The Coexistence of Pathogenic Fungi in Certain Chronic Pulmonary Diseases: With Especial Reference to Pulmonary Tuberculosis (A Preliminary Report)

  1943cited by this paper

• Saccharomyces cerevisiae isolated in a degloving baker's machine injury, a contamination or infection - a case report.

  2026cites this paper
• Functional analysis of Candida albicans Cdr1 through homologous and heterologous expression studies

  2025cites this paper
• Advantages of multi-strain probiotics in the treatment of infectious diseases in children

  2025cites this paper
• Epidemiology of Saccharomyces fungemia: a systematic review.

  2023cites this paper
• Molecular detection of Aspergillus in respiratory samples collected from patients at higher risk of chronic pulmonary aspergillosis.

  2022cites this paper
• Case report of a Saccharomyces cerevisiae lung parenchyma infection in an immunocompetent 64-year-old male with a Zenker diverticulum

  2022cites this paper
• Selection on plastic adherence leads to hyper-multicellular strains and incidental virulence in the budding yeast

  2022cites this paper
• The Flo Adhesin Family

  2021cites this paper
• Bloodstream infection by Saccharomyces cerevisiae in a COVID-19 patient receiving probiotic supplementation in the ICU in Brazil

  2021cites this paper
• Uncommon Yeasts and Molds Causing Human Disease

  2020cites this paper
• Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis

  2020cites this paper
• Safety of Probiotics in Health and Disease

  2019cites this paper
• Biochemical characteristics, virulence traits and antifungal resistance of two major yeast species isolated from kefir:Kluyveromyces marxianusandSaccharomyces unisporus

  2019cites this paper
• The Interaction of Human Pathogenic Fungi With C-Type Lectin Receptors

  2018cites this paper
• Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Candida glabrata and Saccharomyces cerevisiae

  2018cites this paper
• Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use

  2018cites this paper
• [Saccharomyces cerevisiae invasive infection: The first reported case in Morocco].

  2017cites this paper
• Fulminant Hepatic Failure and Fatal Cerebral Edema Following Clostridium perfringens Bacteremia: Case Report and Review of Literature

  2017cites this paper
• Saccharomyces cerevisiae osteomyelitis in an immunocompetent baker

  2016cites this paper
• Effects of Yeast and Bacterial Commensals and Pathogens of the Female Genital Tract on the Transepithelial Electrical Resistance of HeLa Cells

  2016cites this paper
• A two-stage microresistive pulse immunosensor for pathogen detection.

  2016cites this paper
• Whole Genome Analysis of 132 Clinical Saccharomyces cerevisiae Strains Reveals Extensive Ploidy Variation

  2016cites this paper
• Review of current methods for characterizing virulence and pathogenicity potential of industrial Saccharomyces cerevisiae strains towards humans.

  2015cites this paper
• Determination of MICING: a new assay for assessing minimal inhibitory concentration for invasive growth

  2015cites this paper
• Infection Due to Non-Candidal Yeasts

  2015cites this paper
• Mycotoxigenic Fungi and Mycotoxin Contamination of Traditionally Fermented Milk (Mursik) in Soliat Location Kericho County, Kenya.

  2015cites this paper
• Label free and multiplexed immunosensor chips for detection of macromolecular and cellular biomarkers

  2015cites this paper
• Steroid-binding receptors in fungi: implication for systemic mycoses

  2015cites this paper
• Human lactoferrin triggers a mitochondrial- and caspase-dependent regulated cell death in Saccharomyces cerevisiae

  2015cites this paper
• Characterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in Virulence

  2015cites this paper
• Saccharomyces Cerevisiae Fungemia, a Possible Consequence of the Treatment of Clostridium Difficile Colitis with a Probioticum

  2014cites this paper
• Are We Biologically Safe with Snow Precipitation? A Case Study in Beijing

  2013cites this paper
• [Saccharomyces cerevisiae infections].

  2013cites this paper
• ynergistic antifungal activity of statin – azole associations as witnessed y Saccharomyces cerevisiae-and Candida utilis-bioassays and ergosterol uantification aría

  2013cites this paper
• Actividad antifungica de extractos de plantas usadas en medicina popular en Argentina

  2013cites this paper
• Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.

  2013cites this paper
• Saccharomyces boulardii fungemia caused by treatment with a probioticum

  2012cites this paper
• Bottles Culture Bloodstream Pathogens from Blood Identification of Bacterial and Yeast Ionization Mass Spectrometry for Rapid Use of PCR Coupled with Electrospray

  2012cites this paper
• Risk Assessment Summary Conducted Pursuant to the New Substances Notification Regulations (Organisms) (NSNR[O]) of the Canadian Environmental Protection Act, 1999

  2012cites this paper
• Choosing the right lifestyle: adhesion and development in Saccharomyces cerevisiae.

  2012cites this paper
• Saccharomyces cerevisiae infection: an unusual pathogen in the ICU.

  2011influential citation
• Safety of Probiotics to Reduce Risk and Prevent or Treat Disease

  2011cites this paper
• Larrea divaricata Cav.: Scientific evidence showing its beneficial effects and its wide potential application

  2011cites this paper
• Genotyping of Saccharomyces cerevisiae strains by interdelta sequence typing using automated microfluidics

  2011cites this paper
• Infecção por Saccharomyces cerevisae: uma infecção atípica em UTI

  2011influential citation
• Rhodotorula, Saccharomyces, Malassezia, Trichosporon, Blastoschizomyces, and Sporobolomyces

  2011cites this paper
• Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul‐Ehrlich‐Society for Chemotherapy

  2011cites this paper
• Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit.

  2010influential citation
• Evaluation of antifungal activity of Calotropis gigantea latex extract: an in vitro study.

  2010cites this paper
• Differences in activation of MAP kinases and variability in the polyglutamine tract of Slt2 in clinical and non‐clinical isolates of Saccharomyces cerevisiae

  2010cites this paper
• Use of PCR Coupled with Electrospray Ionization Mass Spectrometry for Rapid Identification of Bacterial and Yeast Bloodstream Pathogens from Blood Culture Bottles

  2010cites this paper
• Über den therapeutischen Nutzen von Hefezellen-ein historischer Überblick

  2010cites this paper
• Scientific Opinion on the substantiation of health claims related to non characterised bacteria and yeasts pursuant to Article 13(1) of Regulation (EC) No 1924/2006

  2010cites this paper
• Serious Infections Caused by Uncommon Yeasts

  2010cites this paper
• Emerging Systemic Yeast Pathogens

  2010cites this paper
• Evolutionary Implications and Genetic Basis of Peroxide Survival in Saccharomyces cerevisiae

  2009cites this paper
• Chapter 10 – Infections caused by non-Candida, non-Cryptococcus yeasts

  2009cites this paper
• CHAPTER 29 – Hematogenously disseminated fungal infections

  2009cites this paper
• Saccharomyces cerevisiae: Population Divergence and Resistance to Oxidative Stress in Clinical, Domesticated and Wild Isolates

  2009cites this paper
• Two Cases of Vaginitis Caused by Itraconazole-Resistant Saccharomyces cerevisiae and a Review of Recently Published Studies

  2008cites this paper
• Comparative genomics of wild type yeast strains unveils important genome diversity

  2008cites this paper
• Chemical-genetic approaches for exploring the mode of action of natural products.

  2008cites this paper
• Traitements non antibiotiques des enterocolites infectieuses

  2008cites this paper
• Immunological and central nervous system changes in mice suffering fromStaphyloccocus aureus and treated withSaccharomyces cerevisiae var.vini living cells

  2008cites this paper
• Nutrition support challenges in hematopoietic stem cell transplant patients.

  2008cites this paper
• Quantitative agar-invasion assay.

  2008cites this paper
• Immunological and Central Nervous System Changes in Mice Suffering from Staphyloccocus aureus and Treated with Saccharomyces cerevisiae var . vini Living Cells

  2008cites this paper
• Characterization of alpha-cyclodextrin inclusion complexes with trans-cinnamic acid in an acid-based beverage system

  2008cites this paper
• Quantitative real time PCR assays for the enumeration of Saccharomyces cerevisiae and the Saccharomyces sensu stricto complex in human feces.

  2007cites this paper
• Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed acute myeloid leukaemia

  2007cites this paper
• Subgingival plaque microbiota in HIV positive patients.

  2007cites this paper
• Update of Medically Important Yeasts and a Practical Approach to Their Identification

  2007cites this paper
• Yeasts in food and beverages

  2006cites this paper
• Functional genomic approaches to fungal pathogenesis, drug target validation, and antifungal drug discovery.

  2006cites this paper
• A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors

  2006cites this paper
• Saccharomyces cerevisiae: an emerging and model pathogenic fungus.

  2006cites this paper
• The Public Health and Probiotic Significance of Yeasts in Foods and Beverages

  2006cites this paper
• Invasive Saccharomyces infection: a comprehensive review.

  2005cites this paper
• Saccharomyces cerevisiae fungemia: an emerging infectious disease.

  2005influential citation
• Diagnose und Therapie von Pilzinfektionen und der Pneumozystis-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen

  2005cites this paper
• Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.

  2005cites this paper
• Characterization of Saccharomyces cerevisiae natural populations for pseudohyphal growth and colony morphology.

  2005cites this paper
• Saccharomyces boulardii induced sepsis: Successful therapy with voriconazole after treatment failure with fluconazole

  2005cites this paper
• [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].

  2005cites this paper
• Abscesso HepÆtico Fœngico: AnÆlise SecundÆria de Dados Fungal Liver Abscess: Secondary Analysis of Cases

  2004cites this paper
• SACCHAROMYCES CEREVISIAE FUNGEMIA IN A HEAD AND NECK CANCER PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE

  2004cites this paper
• In vitro activities of voriconazole (UK‐109, 496), fluconazole, itraconazole and amphotericin B against 132 non‐albicans bloodstream yeast isolates (CANARI study)

  2004cites this paper
• Allergic Bronchopulmonary Fungal Disease Caused by Saccharomyces cerevisiae

  2004cites this paper
• Antibacterial and antifungal survey in plants used in indigenous herbal-medicine of south east regions of Iran

  2004cites this paper
• Molecular characterization of clinical Saccharomyces cerevisiae isolates and their association with non-clinical strains.

  2004cites this paper
• Comparison of salivary IgA and systemic IgA and IgG antibodies to Saccharomyces cerevisiae in HIV-infected subjects

  2003cites this paper
• Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients.

  2002cites this paper
• Correlation of the frequency of petite formation by isolates of Saccharomyces cerevisiae with virulence.

  2002cites this paper
• Seven cases of fungemia with Saccharomyces boulardii in critically ill patients

  2002cites this paper
• Fatal Saccharomyces cerevisiae Aortic Graft Infection

  2002cites this paper
• [Non-antibiotic treatments for infectious enterocolitis].

  2002cites this paper
• Drug discovery : the impact of genomics

  2002cites this paper
• Uncommon opportunistic fungi: new nosocomial threats.

  2001cites this paper
• Saccharomyces cerevisiae Sepsis in a 35-Week-Old Premature Infant. A Case Report

  2001cites this paper
• Endocarditis infecciosa por levaduras

  2001cites this paper